Pharma company ranking based on access to medicine in developing countries 2022

Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022

Loading statistic...
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

November 2022



Survey time period

as of November 2022

Supplementary notes

The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.
Merck & Co., Inc. is known as MSD outside the US and Canada. Merck KGaA’s healthcare division is known as EMD Serono in the US and Canada.

Open this statistic in...
Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you



Key company data






Research and Development


Further related statistics

Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.